AN2 Therapeutics, Inc.
ANTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51 | -$65 | -$41 | -$22 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $8 | $4 | $1 |
| Change in WC | -$3 | $6 | $4 | $0 |
| Other Non-Cash | -$3 | -$3 | -$1 | $0 |
| Operating Cash Flow | -$49 | -$53 | -$33 | -$20 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$47 | -$132 | -$94 | -$77 |
| Inv. Sales/Matur. | $101 | $89 | $72 | $27 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $55 | -$43 | -$22 | -$50 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $85 | $70 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$0 | $79 |
| Financing Cash Flow | $0 | $85 | $70 | $79 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6 | -$12 | $15 | $8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16 | $27 | $12 | $4 |
| End Cash | $21 | $16 | $27 | $12 |
| Free Cash Flow | -$49 | -$53 | -$33 | -$20 |